Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Analysis Of Generic Drug Companies From India
Nov 24, 2008 12:19 PM
- The Incredible India Growth Story - Interrupted
Oct 19, 2008 02:09 PM
- Yiannis Mostrous: If Obama Wins ... Get 'Reddy'
Oct 08, 2008 12:11 PM
- China Points the Way to Profits as the New Global Manufacturing Leader
Aug 13, 2008 11:56 PM
- India’s Reliability Provides a Razor Thin Edge Over China
Aug 12, 2008 08:55 AM
- Ready for Reddy
Aug 11, 2008 07:21 AM
- UPDATE: Dr Reddy's Files Declaratory Judgment On Nexium
Jun 06, 2008 05:29 AM
- Dr Reddy's Files Declaratory Judgment On AstraZeneca's Nexium
Jun 06, 2008 04:31 AM
- Dr Reddy's Files Declaratory Judgment On AstraZeneca's Nexium
Jun 06, 2008 04:31 AM
- UPDATE: Dr Reddy's: Mulling Options To Expedite Nexium Case
May 28, 2008 06:46 AM
- Dr. Reddy’s Launches Authorized Generic Version of Imitrex®* Tablets
Nov 24, 2008 08:28 AM
- Dr. Reddy's Q2 FY09 Revenue at Rs. 16,151 Million, EBITDA at Rs. 2,746 Million, PAT at Rs. 1,212 Million
Oct 23, 2008 06:09 AM
- Promius Pharma, LLC Launches EpiCeram(R) Skin Barrier Emulsion
Oct 14, 2008 08:20 AM
- Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
Oct 14, 2008 06:48 AM
- Promius Pharma, LLC Launches EpiCeram(R) Skin Barrier Emulsion
Oct 14, 2008 06:01 AM
- Dr. Reddy's to Release Q2 FY09 Results on October 23, 2008; Earnings Call Slated for October 23, 6.30 PM IST/9.00 AM EST
Oct 13, 2008 03:54 AM
- Dr. Reddy's Formally Announces its US Specialty Business, Promius Pharma, LLC.
Sep 18, 2008 07:40 AM
- CORRECTING and REPLACING Cosmederm Technologies Announces Partnership with Dr. Reddy's for Indian Distribution of Proprietary Skin Care Products
Sep 03, 2008 08:45 PM
- Cosmederm Technologies Announces Partnership with Dr. Reddy's for Indian Distribution of Proprietary Skin Care Products
Sep 03, 2008 03:04 AM
- Dr. Reddy's Q1 FY09 Revenue at Rs. 15,038 Million; EBITDA at Rs. 2,710 Million, PAT at Rs. 1,346 Million
Jul 21, 2008 05:02 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
RDY
|
Compare to S&P
|
| YTD |
-51.16 %
|
-19.98 %
|
| 4 Weeks |
4.85 %
|
13.33 %
|
| 12 Weeks |
-32.29 %
|
-6.14 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 5.26 %
|
|
EPS Growth in Last Year: -50.00 %
|
|
Sales Growth in Last Quarter: -0.57 %
|
|
Sales Growth in Last Quarter: 9.09 %
|
|
|
